» Articles » PMID: 24662727

In Vivo Effects of 17β-estradiol on Cardiac Na(+)/K(+)-ATPase Expression and Activity in Rat Heart

Overview
Date 2014 Mar 26
PMID 24662727
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In this study the in vivo effects of estradiol in regulating Na(+)/K(+)-ATPase function in rat heart was studied. Adult male Wistar rats were treated with estradiol (40μg/kg, i.p.) and after 24h the animals were sacrificed and the heart excised. Following estradiol administration, cardiac Na(+)/K(+)-ATPase activity, expression of the α1 subunit, and phosphorylation of the α1 subunit were significantly increased. These animals also had significantly decreased levels of digoxin-like immunoreactive factor(s). Na(+) levels were also significantly reduced but to a level that was still within the normal physiological range, highlighting the ability of the Na(+)/K(+)-ATPase to balance the ionic composition following treatment with estradiol. Estradiol treated rats also showed increased phosphorylation of protein kinase B (Akt), and extracellular-signal-regulated kinase 1/2 (ERK1/2). We therefore suggest a role for Akt and/or ERK1/2 in estradiol-mediated regulation of cardiac Na(+)/K(+)-ATPase expression and activity in rat heart.

Citing Articles

The involvement of Akt, mTOR, and S6K in the in vivo effect of IGF-1 on the regulation of rat cardiac Na/K-ATPase.

Banjac K, Obradovic M, Zafirovic S, Essack M, Gluvic Z, Sunderic M Mol Biol Rep. 2024; 51(1):517.

PMID: 38622478 DOI: 10.1007/s11033-024-09451-3.


Estrogenic Modulation of Ionic Channels, Pumps and Exchangers in Airway Smooth Muscle.

Romero-Martinez B, Sommer B, Solis-Chagoyan H, Calixto E, Aquino-Galvez A, Jaimez R Int J Mol Sci. 2023; 24(9).

PMID: 37175587 PMC: 10178541. DOI: 10.3390/ijms24097879.


The Na/K-ATPase: A potential therapeutic target in cardiometabolic diseases.

Obradovic M, Sudar-Milovanovic E, Gluvic Z, Banjac K, Rizzo M, Isenovic E Front Endocrinol (Lausanne). 2023; 14:1150171.

PMID: 36926029 PMC: 10011626. DOI: 10.3389/fendo.2023.1150171.


Anisodamine Ameliorates Hyperkalemia during Crush Syndrome through Estradiol-Induced Enhancement of Insulin Sensitivity.

Yu J, Fan B, Guo J, Shen Y, Hu Y, Liu X Front Pharmacol. 2019; 10:1444.

PMID: 31849684 PMC: 6902024. DOI: 10.3389/fphar.2019.01444.


Marinobufagenin and left ventricular mass in young adults: The African-PREDICT study.

Strauss M, Smith W, Kruger R, Wei W, Fedorova O, Schutte A Eur J Prev Cardiol. 2018; 25(15):1587-1595.

PMID: 29993282 PMC: 6209078. DOI: 10.1177/2047487318788140.